Clinical Trial Update: Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates [NA]

View source ↗

Summary

This update reports the completion of a clinical trial evaluating sibutramine for reducing weight gain and improving smoking cessation, in the context of cardio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity

Drugs mentioned

• Meridia (sibutramine)

Snippet

Sponsor: University of Tennessee | Conditions: Cardiovascular Diseases, Heart Diseases | NA | Status: COMPLETED